192 related articles for article (PubMed ID: 15116266)
1. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.
Aznar J; Mira Y; Vayá A; Corella D; Ferrando F; Villa P; Estellés A
Thromb Haemost; 2004 May; 91(5):1031-4. PubMed ID: 15116266
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
3. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
[TBL] [Abstract][Full Text] [Related]
4. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
[TBL] [Abstract][Full Text] [Related]
5. Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls.
Krajcoviechova A; Wohlfahrt P; Mayer O; Vanek J; Hajkova J; Hlinovsky D; Kvasnicka T; Tremblay J; Hamet P; Filipovsky J; Kvasnicka J; Cifkova R
Atherosclerosis; 2015 Jun; 240(2):446-52. PubMed ID: 25897999
[TBL] [Abstract][Full Text] [Related]
6. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.
Eterović D; Titlić M; Culić V; Zadro R; Primorac D
Clin Appl Thromb Hemost; 2007 Apr; 13(2):188-93. PubMed ID: 17456629
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Beye A; Pindur G
Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.
Lichy C; Reuner KH; Buggle F; Litfin F; Rickmann H; Kunze A; Brandt T; Grau A
Cerebrovasc Dis; 2003; 16(1):83-7. PubMed ID: 12766367
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.
Lopaciuk S; Bykowska K; Kwiecinski H; Mickielewicz A; Czlonkowska A; Mendel T; Kuczynska-Zardzewialy A; Szelagowska D; Windyga J; Schröder W; Herrmann FH; Jedrzejowska H
Clin Appl Thromb Hemost; 2001 Oct; 7(4):346-50. PubMed ID: 11697722
[TBL] [Abstract][Full Text] [Related]
14. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale.
Favaretto E; Sartori M; Conti E; Legnani C; Palareti G
Thromb Res; 2012 Nov; 130(5):720-4. PubMed ID: 22909823
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients.
Celiker G; Can U; Verdi H; Yazici AC; Ozbek N; Atac FB
Clin Appl Thromb Hemost; 2009; 15(4):415-20. PubMed ID: 18387982
[TBL] [Abstract][Full Text] [Related]
16. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke.
Slooter AJ; Rosendaal FR; Tanis BC; Kemmeren JM; van der Graaf Y; Algra A
J Thromb Haemost; 2005 Jun; 3(6):1213-7. PubMed ID: 15946211
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses.
Laugesaar R; Kahre T; Kolk A; Uustalu U; Kool P; Talvik T
Acta Paediatr; 2010 Aug; 99(8):1168-74. PubMed ID: 20337781
[TBL] [Abstract][Full Text] [Related]
18. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
20. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
Kim RJ; Becker RC
Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
